Avelumab vs Docetaxel for Previously Treated Advanced NSCLC: Primary Analysis of the Phase 3 JAVELIN Lung 200 Trial
Date
2018Author
Uslu, R.
Szczesna, A.
Polychronis, A.
Krzakowski, M.
Lee, J.
Calabro, L.
Frontera, O.
Ellers-Lenz, B.
Bajars, M.
Ruisi, M.
Parki, K.
Ozguroglu, M.
Barlesi, F.
Vansteenkiste, J.
Spigel, D.
Ishii, H.
Garassino, M.
De Marinis, F.
Metadata
Show full item recordCollections
- Makale [92796]